Ultragenyx Pharmaceutical Inc - Company Profile
Powered by
All the data and insights you need on Ultragenyx Pharmaceutical Inc in one report.
$295
- Save hours of research time and resources with
our up-to-date Ultragenyx Pharmaceutical Inc Strategy Report
- Understand Ultragenyx Pharmaceutical Inc position in the market,
performance and strategic initiatives.
- Gain competitive edge and increase your
chances of success
View up-to-date information on Ultragenyx Pharmaceutical Inc patents, including inventor and filing insights.
Patent Trends
Publication Identifier | Document Type | Title | Classification-CPC | Publication Date |
---|---|---|---|---|
IL294781A | Application | Gene therapy for treating cdkl5 deficiency disorder | A01K2217/075; A01K2227/105; A01K2267/0306; A61K35/761; A61K38/00; A61K48/005; A61K48/0058; A61K48/0075; C12N15/86; C12N2750/14143; C12N9/1205; C12Y207/11022 | September 01, 2022 |
EP4038194A1 | Application | VERFAHREN ZUR VERBESSERTEN THERAPEUTISCHEN VERWENDUNG VON REKOMBINANTEM AAV | A61K31/573; A61K45/06; A61P37/06; A61P43/00; C12N15/86; C12N2750/14143 | August 10, 2022 |
AU2021218703A1 | Application | Gene therapy for treating CDKL5 deficiency disorder | A01K2217/075; A01K2227/105; A01K2267/0306; A61K35/761; A61K38/00; A61K48/005; A61K48/0058; A61K48/0075; C12N15/86; C12N2750/14143; C12N9/1205; C12Y207/11022 | July 28, 2022 |
AU2021217143A1 | Application | Chaotropic agents for reducing formation of double-stranded RNA | A61P35/00; A61P43/00; C12Q1/6806 | July 21, 2022 |
US20220227703A1 | Application | CREATINE PRODRUGS, COMPOSITIONS AND METHODS OF USE THEREOF | C07B2200/05; C07B59/001; C07B59/002; C07C279/22; C07D213/82; C07D273/02; C07D498/10 | July 21, 2022 |
Top Inventors by Filings (Count by publication)
Name | Count |
---|
Still looking?
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Explorer
Access more premium companies when you subscribe to Explorer
Get in touch about GlobalData Company reports
Contact the team or request a demo to find out how our data can drive your business forward